Posters and Presentations

Each year, the ARUP Institute for Clinical and Experimental Pathology® presents at more than 200 conferences, workshops, annual meetings, and symposiums for several national and international organizations. Recent posters and presentations are listed below.

Request a poster.

MAY 2016

Pathology Informatics Summit (PI-2016)
Pittsburgh, PA, May 2–26, 2016

Smock K—Poster
Rudolf J, Smock K, Jackson B, Schmidt R. Benchmarking utilization with population prevalence data: a novel use of national census data.

Clinical Virology Symposium (CVS)
Daytona Beach, FL, May 19–22, 2016

Elgort M, Hillyard D—Poster
Elgort M, Wilson A, Hillyard D. Evaluation of multiple EBV standard panels on the ELITe InGenius sample to result platform.

Pyne MT, Mallory M, Schlaberg R, and Hillyard DR—Poster
Pyne MT, Mallory M, Xie H, Mei Y, Schlaberg R, and Hillyard DR. Sequencing of the Hepatitis D virus RNA WHO international standard.

APRIL 2016

Endocrine Society (ENDO)
Boston, MA, April 1–4, 2016

Kushnir MM, Straseski JA—Poster
Kushnir MM, Straseski JA. Age and gender-related variation in concentrations of parathyroid hormone-related protein measured by LC-MS/MS.

Society for Inherited Metabolic Disorders (SIMD)
Ponte Vedra Beach, FL, April 3–6, 2016

De Biase I, Liu A, Yuzyuk T, Pasquali M, Longo N—Poster
De Biase I, Viau KS, Liu A, Yuzyuk T, Botto LD, Pasquali M, Longo N. Diagnosis, treatment and clinical outcome of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency.

Yuzyuk T, Liu A, De Biase I, Longo N, Pasquali M—Poster
Yuzyuk T, Liu A, Thomas A, Wilson JE, De Biase I, Longo N, Pasquali M. Simultaneous quantification of alpha-aminoadipic semialdehyde/piperideine-6-carboxylate and pipecolic acid in plasma and urine.

Yuzyuk T, Liu A, De Biase I, Pasquali M, Longo N—Poster
Yuzyuk T, Thomas A, Liu A, De Biase I, Viau K, Botto L, Pasquali M, Longo N. Lysine restriction and arginine supplementation in treatment of two patients with pyridoxine dependent epilepsy.

European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Amsterdam, Netherlands, April 9–12, 2016

Bajaj AO, Saraswat S, Barker A, Hillyard D—Poster
Bajaj AO, Saraswat S, Barker A, Hillyard D. Mycobacterium identification and characterization utilizing ultra-high-field Orbitrap top-down mass spectrometry.

Thrombosis and Hemostasis Summit of North America (THSNA)
Chicago, IL, April 14–16, 2016

Crist RA, Heikal NM, Rodgers GM, Smock KJ—Poster
Crist RA, Heikal NM, Rodgers GM, Smock KJ. Avoiding underestimation of protein S activity in APC resistant specimens.

ASM Conference on Candida and Candidiasis
Seattle, WA, April 13–17, 2016

Tardif KD, Schlaberg R, Hanson KE—Poster
Tardif KD, Schlaberg R, Hanson KE. Development of real-time PCR and sequencing assays for the direct detection of candida species and FKS mutations linked to echinocandin resistance.

MARCH 2016

United States and Canadian Academy of Pathology (USCAP)
Seattle, WA, Mar 12–18, 2016

Salama ME, Patel JL, Paxton CN, Xu X, Perkins SL, Li KD—Presentation
Brown AF, Salama ME, Patel JL, Paxton CN, Xu X, Perkins SL, Li KD. Correlation between PD-L1 protein expression and 9p24.1 amplification in EBV-positive DLBCL of the eldery.

Szankasi P, Kelley TW—Poster
VanNess M, Szankasi P, Frizzell K, Shen W, Kelley TW. Analysis of ASXL1 mutations in a large series of myeloid malignancies.

Kelley TW—Poster
Wang SA, Tam W, Tsai A, Arber DA, Hasserjian RP, Geyer JT, George T, Czuchlewski DR, Foucar K, Rogers HJ, Hsi E, Rea B, Bagg A, Dal-Cin P, Kelley TW, Verstovsek S, Bueso-Ramos C, Orazi A. Targeted next-generation sequencing (NGS) of chronic eosinophilic leukemia, not otherwise specified (CEL, NOS) and of idiopathic hypereosinophilic syndrome (HES).

American College of Medical Genetics and Genomics (ACMG)
Tampa, FL, Mar 8–12, 2016

Ha Y, Morris A, Damjanovich-Colmenares K, Donahue-Wooderchak W, Sumner K, Mao R, Best DH, Bayrak-Toydemir P—Poster
Ha Y, Morris A, Damjanovich-Colmenares K, Donahue-Wooderchak W, Sumner K, Mao R, Best DH, Bayrak-Toydemir P. Retrospective analysis of the periodic fever syndrome, next-generation sequencing, and aCGH clinical assay.

Pham HT, Ha Y, Pont-Kingdon G, Lyon E—Poster
Pham HT, Ha Y, Pont-Kingdon G, Lyon E. SMN copy number determination by MLPA and digital PCR: a comprehensive approach to carrier and diagnostic testing for SMA.

Melis R, Johnson-Davis k, Paul E, McMillin G—Poster
Melis R, Johnson-Davis k, Paul E, McMillin G. Implementation of the TaqMan® OpenArray® Genotyping Platform in a clinical thiopurine s-methyltransferase (TPMT) genotype-phenotype study.

Wooderchak-Donahue W, Bayrak-Toydemir P—Poster
Wooderchak-Donahue W, Tvrdik T, Rope AF, VanSant-Webb C, Mesley R, Bull DA, Yetman AT, Plant P, Bayrak-Toydemir P. Identification of novel SMAD3 mutations in families with variable Marfan-like clinical findings featuring aortopathy.

Sumner KL, Ha Y, Paul E, Morris A, Bayrak-Toydemir P, Best HD—Poster
Sumner KL, Ha Y, Paul E, Morris A, Bayrak-Toydemir P, Elliott GC, Best HD. BMPR2 gene promoter mutation c.-669G>A is a rare finding in pulmonary arterial hypertension.

Andersen E—Presentation
Thorland E, Andersen E, Burnside R, Herriges J, Jobanputra V, Kantarci S, Kearney H, Lorentz C, Pineda-Alvarez D, Ritter D, Risheg H, Shen Y, Speevak M, Aradhya S, Riggs E, Martin CL, on behalf of the Clinical Genome (ClinGen) Resource. Dosage sensitivity curation of ACMG genes recommended for reporting of secondary findings.

McMillin G—Poster
Kamlan V and the PGx Nomenclature Workgroup. Pharmacogenetic allele nomenclature: international workgroup recommendations for test result reporting.

Procter M, Pham HT, Pont-Kingdon G, Lyon E, Rong M—Poster
Procter M, Pham HT, Pont-Kingdon G, Lyon E, Rong M. Non-NGS approach to carrier mutation panel screening for cystic fibrosis and Ashkenazi Jewish diseases.

FEBRUARY 2016

Genomics and Personalized Medicine
Banff, Canada, February 7–11, 2016

Gligorich KM, Hellwig S, Bronner M—Poster
Gligorich KM, Hellwig S, Kennedy B, Baker D, Fuertes C, Bronner M. Development of a next-generation sequencing test to detect low frequency variants in cell-free circulating tumor DNA.

Mass Spectrometry: Applications to the Clinical Laboratory (MSACL)
Palm Springs, CA, February 21–25, 2016

Kushnir MM, Rockwood AL, Strathmann FG—Poster
Kushnir MM, Tennison C, Rockwood AL, Strathmann FG. LC-MS/MS measurements of parathyroid hormone-related protein (PTHrP): negative correlation between age and PTHrP concentrations in CSF.

Clark ZD, Frank EL, Strathmann FG—Presentation
Clark ZD, Frank EL, Strathmann FG. Are we getting what we paid for with a 13C-labeled internal standard?

Rule GS, Rockwood AL—Poster
Rule GS, Rockwood AL. Results from a seven month trial of single point calibration.

Smith K, Barker AP, Strathmann FG—Poster
Smith K, Barker AP, Strathmann FG. Qualitative analysis for multiple drugs in urine by liquid chromatography time of flight mass spectrometry (LC-TOF/MS).

Merrigan SD, Slawson M, Johnson-Davis KL—Poster
Merrigan SD, Slawson M, Auger S, Johnson-Davis KL. LDTD-MS/MS method for quantitative analysis of four immunosuppressant drugs in whole blood and cost analysis comparison to LC-MS/MS.

Ray JA, Kushnir MM, Strathmann FG—Presentation
Ray JA, Kushnir MM, Meikle AW, Strathmann FG. Drug stimulated endocrinopathy: impact of opiates on free hormone concentrations.

Kish-Trier E, Liu A, Erali M, and Yuzyuk T—Poster
Kish-Trier E, Liu A, Erali M, and Yuzyuk T. Quantitation of 22 long chain fatty acids by GC-NCI-MS in serum and plasma.

JANUARY 2016

American Federation for Medical Research (AFMR)
Carmel, CA, January 28–30, 2016

Martins TB, Hill HR—Poster
Martins TB, Teufel RA, Hill HR. Laboratory assays for aiding the diagnosis of chronic urticaria.

Hill HR, Martins TB, Kumanovics A—Presentation
Hill HR, Augustine NH, Miles LM, Rejali JH, Woodbury K, Pasi B, Martins TB, Kumanovics A. Effects of interferon gamma on the respiratory burst of variant x-linked chronic granulomatous disease patients versus classic x-linked dise.